Developer docs
API playgroundTry for free, no card

Search company profiles

Basecare

Full company profile

uuid000356m

Namestring
Basecare
Legal namestring
BASECARE
Websiteurl
basecare.cn
Company typeenum
Private
Founded yearint
2010
Descriptiontext

Basecare (贝康医疗, HKEX: 2170) is a Suzhou, China-headquartered medical technology company founded in 2010 that manufactures devices and consumables for assisted reproductive technology (ART), specifically in vitro fertilization (IVF) and preimplantation genetic testing (PGT). The company serves fertility clinics, hospital reproductive medicine departments, and to a lesser extent research institutions, with a vertically specialized product portfolio spanning genetic screening (BaseECS, BasePGT, BaseCNV, BaseNIPT), embryo culture and observation systems (Gems, Geri, Gavi), sperm and reproductive bioanalyzers (DA500, BS1000, DFI, BFC260, BKA210, BZG01, BET01), quality control kits (DFI-QC, BFC260-QC, SEM-QC), cryopreservation consumables (BCT, BSG, BaseStation), and an integrated IVF laboratory software suite (BK-RCMS, BK-RMRS, BK-CMS, BK-LMS, BK-SMS, BK-QCS, BK-IVS).

The company operates on a three-stream revenue model: capital equipment sales (instruments such as DA500, BS1000, Geri, Gavi to fertility clinics), recurring revenue from reagents, culture media, quality control kits, and other consumables used in IVF procedures, and subscription-style or licensing revenue from laboratory information and workflow management software (BaseStation, BK series). The BK-IVS embryo vision tracking product introduces AI-assisted image analysis to embryology workflows, while the remainder of the catalog relies on conventional molecular and clinical laboratory instrumentation. Approximately 501–1,000 employees support engineering, manufacturing, and sales activities.

Basecare goes to market as a B2B medical device company primarily through direct enterprise sales engagements with clinics and hospitals, supplemented by a professional website (basecare.cn), a customer service hotline, and brand-building presence on Chinese social platforms (Douyin, Xiaohongshu, Weibo, Toutiao). The company has progressed through seed, Series A (~$15.3M, 2017), and Series C (~$21.1M, 2020) funding rounds and listed on the Hong Kong Stock Exchange (ticker 2170). Disclosed financials through 2025 indicate revenue scaled from 2021 through 2024 before contracting in 2025, with EBITDA, operating income, and net income remaining negative throughout the reported period — i.e., Basecare is a growth-stage, loss-making medtech that has built a broad product footprint but has not yet demonstrated profitability.

Short descriptiontext

Basecare (贝康医疗, HKEX: 2170) is a Suzhou, China-based medical device company founded in 2010 that manufactures IVF and preimplantation genetic testing (PGT) instruments, reagents, and laboratory software for fertility clinics, hospital reproductive departments, and reproductive research institutions.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
501–1,000
akta.pro rankint
HeadquartersSuzhou, China
HQ citystring
Suzhou
HQ countrystring
China
HQ regionstring
Asia
Markets served

Serves global market

Keyword5 values
preimplantation genetic testing, IVF diagnostic equipment, embryo culture systems, reproductive genetics, fertility laboratory software
Industry4 codes
1Prenatal, Newborn & Reproductive Diagnostics (NIPT, IVF/PGT, newborn screening)
CodeHLAAALAJPrimaryYes
2Genetic, Cytogenetic & Prenatal Screening IVD
CodeHLAHAAAIPrimaryNo
3Genetic & Prenatal Testing Laboratories
CodeHLAFAMAHPrimaryNo
4Reproductive Endocrinology & Infertility (IVF/Fertility)
CodeHLAKAJACPrimaryNo
NAICS code2 codes
  • Biological Product (except Diagnostic) Manufacturing325414
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code2 codes
  • In Vitro & In Vivo Diagnostic Substances2835
  • Services-Medical Laboratories8071
Product category
IVF and reproductive genetics medical devices
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Medical Diagnostic Instruments
TypeHardware Sales
Description

Sale of IVF and fertility testing instruments including DA500 sperm analyzers and BS1000 biochemical analyzers. One-time capital equipment sales to fertility clinics and hospitals.

basecare.cn
2Diagnostic Reagents and Consumables
TypeOne Time License
Description

PGT testing reagents, culture media, QC kits for sperm analysis, and other consumables used in IVF procedures. Recurring revenue from clinical laboratories.

basecare.cn
3Software Systems
TypeSubscription Recurring
Description

Laboratory information management systems (BaseStation, BK-IVS) and quality control systems for fertility clinics. Potential software licensing and subscription models.

basecare.cn
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Basecare develops and manufactures an integrated suite of IVF and reproductive genetics products, including preimplantation genetic testing kits (BaseECS, BasePGT, BaseCNV, BaseNIPT), diagnostic and sperm analysis instruments (DA500, BS1000), embryo culture and time-lapse observation systems (Gems, Geri, Gavi), sperm DNA fragmentation tests and quality controls (DFI, BFC260, DFI-QC, SEM-QC), cryopreservation consumables, and laboratory information management software (BaseStation, BK suite). Products are sold to fertility clinics, hospital reproductive medicine departments, and research institutions to support embryo screening, embryo culture, and IVF laboratory operations.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Basecare (贝康医疗) offers a comprehensive fertility and reproductive health technology platform consisting of genetic testing products (BaseECS, BasePGT, BaseCNV, BaseNIPT), laboratory equipment (DA500, BS1000, Gems, Geri, Gavi, BZG01, BET01, BaseStation), diagnostic tests (DFI, BFC260, BKA210), quality control products (DFI-QC, BFC260-QC, SEM-QC), consumables (BCT, BSG), and intelligent software management systems (BK-RCMS, BK-RMRS, BK-CMS, BK-LMS, BK-SMS, BK-QCS, BK-IVS). The portfolio covers the entire IVF workflow from genetic screening and diagnosis, embryo culture and monitoring, semen analysis, to cryopreservation storage and laboratory information management.

Product and service27 records
1BaseECS
CategoryReproductive genetics / PGT
Description

Preimplantation embryo screening system used for genetic screening and diagnosis before embryo implantation, targeted at fertility clinics and IVF centers.

2BasePGT
CategoryReproductive genetics / PGT
Description

Preimplantation genetic testing product for screening embryo chromosomal abnormalities and hereditary diseases, used by IVF laboratories.

3BaseCNV
CategoryReproductive genetics / PGT
Description

Chromosomal copy number variation detection product used to analyze chromosome number and structural abnormalities in embryos.

4BaseNIPT
CategoryPrenatal diagnostics
Description

Non-invasive prenatal testing product that detects fetal chromosomal abnormalities through analysis of maternal blood samples.

5DA500
CategoryDiagnostic equipment
Description

Sperm quality analyzer instrument used by reproductive medicine laboratories for sample analysis in andrology workups.

6BS1000
CategoryDiagnostic equipment
Description

Biochemical analyzer instrument used for high-throughput sample analysis in reproductive medicine laboratories.

7Geri Embryo Culture System
CategoryEmbryo culture and observation equipment
Description

Time-lapse embryo culture system used for continuous observation and evaluation of embryo development in IVF procedures.

8Gems Fertilization and Culture Medium
CategoryIVF consumables / culture media
Description

Embryo culture medium product line used for fertilization and embryo culture in IVF procedures.

9Gavi Automated IVF System
CategoryAutomated IVF / cryopreservation equipment
Description

Automated handling / cryopreservation system for safe liquid-nitrogen storage of reproductive cells and embryos in IVF workflows.

10DFI Sperm Function Analysis
CategoryDiagnostic product
Description

Sperm DNA fragmentation index testing system used to assess sperm DNA integrity in male fertility workups.

11DFI-QC Quality Control Kit
CategoryQuality control kits
Description

Quality control kit for sperm DNA fragmentation testing used for validation and QC verification by laboratories.

12BFC260-QC Quality Control Kit
CategoryQuality control kits
Description

Quality control kit for sperm morphology analysis systems.

13SEM-QC Quality Control Kit
CategoryQuality control kits
Description

Quality control kit for high-resolution scanning electron microscope sperm morphology analysis.

14BFC260 Sperm Morphology Analysis
CategoryDiagnostic product
Description

Automated sperm morphology evaluation system used in fertility laboratories.

15BKA210 Sperm Nuclear Analysis
CategoryDiagnostic product
Description

Sperm nuclear analysis product used to evaluate sperm chromatin in fertility diagnostics.

16BZG01 Automated Semen Analyzer
CategoryDiagnostic equipment
Description

Automated semen analyzer instrument used for automated analysis of semen samples in fertility labs.

17BET01 Intelligent Sperm Quality Analysis
CategoryDiagnostic equipment
Description

Intelligent sperm quality analysis system used for automated evaluation of sperm quality parameters.

18BCT Cryopreservation Consumable
CategoryIVF consumables
Description

Cryopreservation straw used for vitrification of embryos and gametes in IVF cryopreservation workflows.

19BSG Cryopreservation Straw
CategoryIVF consumables
Description

Cryopreservation straw used for cryogenic storage of sperm and other samples in fertility laboratories.

20BaseStation Lab Management System
CategoryCryopreservation / lab storage equipment
Description

Intelligent large-capacity liquid nitrogen storage system for safe storage of reproductive cells and embryos in IVF facilities.

21BK-IVS IVF Workflow System
CategoryIVF laboratory software
Description

IVF intelligent visual tracking system providing AI-based visual analysis and tracking of embryo development.

22BK-RCMS Cryo Management Software
CategoryIVF laboratory software
Description

Software for end-to-end management of cryopreserved samples including gametes and embryos.

23BK-RMRS Sample Bank Software
CategoryIVF laboratory software
Description

Software used to manage sample banks for fertility preservation workflows.

24BK-CMS Embryo Lab Monitoring
CategoryIVF laboratory software
Description

Embryo laboratory intelligent monitoring system for real-time monitoring of lab environment and equipment.

25BK-LMS Laboratory Management System
CategoryIVF laboratory software
Description

Comprehensive laboratory management system used for managing reproductive medicine laboratories end-to-end.

26BK-SMS Sample Management System
CategoryIVF laboratory software
Description

Sample management system used for tracking, storage and management of biological samples in fertility labs.

27BK-QCS Quality Control System
CategoryIVF laboratory software
Description

Quality control management system used for analysis and management of laboratory QC data.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Swedish provider of IVF media, consumables, and time-lapse embryo culture (Geri) systems. Direct overlap with Basecare's Gems, Geri, and embryo culture media lines, serving the same fertility clinic customers globally.

TypeDirect peer
Description

Major fertility and women's health company offering IVF lab consumables, devices, and PGT-related services. Comparable as a one-stop integrated IVF/PGT provider selling directly to fertility clinics and hospitals.

TypeDirect peer
Description

Specialty provider of IVF devices, lasers, and time-lapse imaging used in embryo research and ART clinics. Comparable instrument and consumable portfolio aligned with Basecare's DA500, BS1000, and Geri offerings.

TypeDirect peer
Description

China-based genomics and genetic testing leader, including NIPT and PGT services. Most direct domestic competitor in the Chinese PGT/NIPT space, targeting the same hospital and IVF clinic customers as Basecare.

TypeDirect peer
Description

Chinese fertility genetics company focused on PGT-A/PGT-M embryo testing kits. Directly comparable to Basecare's BasePGT and BaseCNV products serving Chinese IVF centers.

TypeBroad incumbent
Description

Dominant global DNA sequencing platform; powers many PGT workflows via sequencer and reagent sales. Broader incumbent with overlapping IVD/PGT technology stack though not a single-clinic integrated IVF supplier.

TypeBroad incumbent
Description

Diversified life sciences tools, diagnostics, and lab services giant. Comparable as upstream supplier of IVF lab instruments and genetic testing reagents, though operates across many end markets.

TypeDirect peer
Description

Provider of time-lapse embryo incubation systems (MIRI) and IVF lab equipment for ART clinics. Direct comparable to Basecare's Geri time-lapse incubator and the integrated IVF workstation segment.

TypeBroad incumbent
Description

Genetic testing company with established PGT (Spectrum) and reproductive health offerings. Comparable in reproductive genetics end-market though focused on US-centric clinical lab service delivery.

TypeEmerging player
Description

Australian-based IVF technology developer behind Gavi (automated vitrification and handling), which Basecare lists in its own portfolio. Directly comparable on automated IVF workflow devices for fertility clinics.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature13 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors4 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Basecare

IVF and reproductive genetics medical devicesbasecare.cn

Basecare (贝康医疗, HKEX: 2170) is a Suzhou, China-based medical device company founded in 2010 that manufactures IVF and preimplantation genetic testing (PGT) instruments, reagents, and laboratory software for fertility clinics, hospital reproductive departments, and reproductive research institutions.

What Basecare does

Basecare (贝康医疗, HKEX: 2170) is a Suzhou, China-headquartered medical technology company founded in 2010 that manufactures devices and consumables for assisted reproductive technology (ART), specifically in vitro fertilization (IVF) and preimplantation genetic testing (PGT). The company serves fertility clinics, hospital reproductive medicine departments, and to a lesser extent research institutions, with a vertically specialized product portfolio spanning genetic screening (BaseECS, BasePGT, BaseCNV, BaseNIPT), embryo culture and observation systems (Gems, Geri, Gavi), sperm and reproductive bioanalyzers (DA500, BS1000, DFI, BFC260, BKA210, BZG01, BET01), quality control kits (DFI-QC, BFC260-QC, SEM-QC), cryopreservation consumables (BCT, BSG, BaseStation), and an integrated IVF laboratory software suite (BK-RCMS, BK-RMRS, BK-CMS, BK-LMS, BK-SMS, BK-QCS, BK-IVS).

The company operates on a three-stream revenue model: capital equipment sales (instruments such as DA500, BS1000, Geri, Gavi to fertility clinics), recurring revenue from reagents, culture media, quality control kits, and other consumables used in IVF procedures, and subscription-style or licensing revenue from laboratory information and workflow management software (BaseStation, BK series). The BK-IVS embryo vision tracking product introduces AI-assisted image analysis to embryology workflows, while the remainder of the catalog relies on conventional molecular and clinical laboratory instrumentation. Approximately 501–1,000 employees support engineering, manufacturing, and sales activities.

Basecare goes to market as a B2B medical device company primarily through direct enterprise sales engagements with clinics and hospitals, supplemented by a professional website (basecare.cn), a customer service hotline, and brand-building presence on Chinese social platforms (Douyin, Xiaohongshu, Weibo, Toutiao). The company has progressed through seed, Series A (~$15.3M, 2017), and Series C (~$21.1M, 2020) funding rounds and listed on the Hong Kong Stock Exchange (ticker 2170). Disclosed financials through 2025 indicate revenue scaled from 2021 through 2024 before contracting in 2025, with EBITDA, operating income, and net income remaining negative throughout the reported period — i.e., Basecare is a growth-stage, loss-making medtech that has built a broad product footprint but has not yet demonstrated profitability.

Basecare firmographics

Firmographics
Name
Basecare
Legal name
BASECARE
Website
https://basecare.cn
Company type
Private
Founded year
2010
Operating status
Operating
Headcount range
501–1,000 employees
Short description
Basecare (贝康医疗, HKEX: 2170) is a Suzhou, China-based medical device company founded in 2010 that manufactures IVF and preimplantation genetic testing (PGT) instruments, reagents, and laboratory software for fertility clinics, hospital reproductive departments, and reproductive research institutions.
Ownership category
akta.pro rank

Basecare industry classification

Industry
Product category
IVF and reproductive genetics medical devices
NAICS
Biological Product (except Diagnostic) Manufacturing (325414), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
In Vitro & In Vivo Diagnostic Substances (2835), Services-Medical Laboratories (8071)
akta.pro primary industry
Prenatal, Newborn & Reproductive Diagnostics (NIPT, IVF/PGT, newborn screening) (HLAAALAJ)
akta.pro secondary industries
Genetic, Cytogenetic & Prenatal Screening IVD (HLAHAAAI), Genetic & Prenatal Testing Laboratories (HLAFAMAH), Reproductive Endocrinology & Infertility (IVF/Fertility) (HLAKAJAC)

Keywords

  • Preimplantation genetic testing
  • IVF diagnostic equipment
  • Embryo culture systems
  • Reproductive genetics
  • Fertility laboratory software

Where Basecare is headquartered

Location

Headquarters

HQ city
Suzhou
HQ country
China
HQ region
Asia

Markets served

Basecare business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain

Revenue model

  1. Medical Diagnostic Instruments: Sale of IVF and fertility testing instruments including DA500 sperm analyzers and BS1000 biochemical analyzers. One-time capital equipment sales to fertility clinics and hospitals.
  2. Diagnostic Reagents and Consumables: PGT testing reagents, culture media, QC kits for sperm analysis, and other consumables used in IVF procedures. Recurring revenue from clinical laboratories.
  3. Software Systems: Laboratory information management systems (BaseStation, BK-IVS) and quality control systems for fertility clinics. Potential software licensing and subscription models.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Basecare product offering

Product offering

Core offering

Basecare develops and manufactures an integrated suite of IVF and reproductive genetics products, including preimplantation genetic testing kits (BaseECS, BasePGT, BaseCNV, BaseNIPT), diagnostic and sperm analysis instruments (DA500, BS1000), embryo culture and time-lapse observation systems (Gems, Geri, Gavi), sperm DNA fragmentation tests and quality controls (DFI, BFC260, DFI-QC, SEM-QC), cryopreservation consumables, and laboratory information management software (BaseStation, BK suite). Products are sold to fertility clinics, hospital reproductive medicine departments, and research institutions to support embryo screening, embryo culture, and IVF laboratory operations.

Product overview

Basecare (贝康医疗) offers a comprehensive fertility and reproductive health technology platform consisting of genetic testing products (BaseECS, BasePGT, BaseCNV, BaseNIPT), laboratory equipment (DA500, BS1000, Gems, Geri, Gavi, BZG01, BET01, BaseStation), diagnostic tests (DFI, BFC260, BKA210), quality control products (DFI-QC, BFC260-QC, SEM-QC), consumables (BCT, BSG), and intelligent software management systems (BK-RCMS, BK-RMRS, BK-CMS, BK-LMS, BK-SMS, BK-QCS, BK-IVS). The portfolio covers the entire IVF workflow from genetic screening and diagnosis, embryo culture and monitoring, semen analysis, to cryopreservation storage and laboratory information management.

Differentiator

Problem solved

Functional benefit

Products and services

  • BaseECS Preimplantation embryo screening system used for genetic screening and diagnosis before embryo implantation, targeted at fertility clinics and IVF centers.
  • BasePGT Preimplantation genetic testing product for screening embryo chromosomal abnormalities and hereditary diseases, used by IVF laboratories.
  • BaseCNV Chromosomal copy number variation detection product used to analyze chromosome number and structural abnormalities in embryos.
  • BaseNIPT Non-invasive prenatal testing product that detects fetal chromosomal abnormalities through analysis of maternal blood samples.
  • DA500 Sperm quality analyzer instrument used by reproductive medicine laboratories for sample analysis in andrology workups.
  • BS1000 Biochemical analyzer instrument used for high-throughput sample analysis in reproductive medicine laboratories.
  • Geri Embryo Culture System Time-lapse embryo culture system used for continuous observation and evaluation of embryo development in IVF procedures.
  • Gems Fertilization and Culture Medium Embryo culture medium product line used for fertilization and embryo culture in IVF procedures.
  • Gavi Automated IVF System Automated handling / cryopreservation system for safe liquid-nitrogen storage of reproductive cells and embryos in IVF workflows.
  • DFI Sperm Function Analysis Sperm DNA fragmentation index testing system used to assess sperm DNA integrity in male fertility workups.
  • DFI-QC Quality Control Kit Quality control kit for sperm DNA fragmentation testing used for validation and QC verification by laboratories.
  • BFC260-QC Quality Control Kit Quality control kit for sperm morphology analysis systems.
  • SEM-QC Quality Control Kit Quality control kit for high-resolution scanning electron microscope sperm morphology analysis.
  • BFC260 Sperm Morphology Analysis Automated sperm morphology evaluation system used in fertility laboratories.
  • BKA210 Sperm Nuclear Analysis Sperm nuclear analysis product used to evaluate sperm chromatin in fertility diagnostics.
  • BZG01 Automated Semen Analyzer Automated semen analyzer instrument used for automated analysis of semen samples in fertility labs.
  • BET01 Intelligent Sperm Quality Analysis Intelligent sperm quality analysis system used for automated evaluation of sperm quality parameters.
  • BCT Cryopreservation Consumable Cryopreservation straw used for vitrification of embryos and gametes in IVF cryopreservation workflows.
  • BSG Cryopreservation Straw Cryopreservation straw used for cryogenic storage of sperm and other samples in fertility laboratories.
  • BaseStation Lab Management System Intelligent large-capacity liquid nitrogen storage system for safe storage of reproductive cells and embryos in IVF facilities.
  • BK-IVS IVF Workflow System IVF intelligent visual tracking system providing AI-based visual analysis and tracking of embryo development.
  • BK-RCMS Cryo Management Software Software for end-to-end management of cryopreserved samples including gametes and embryos.
  • BK-RMRS Sample Bank Software Software used to manage sample banks for fertility preservation workflows.
  • BK-CMS Embryo Lab Monitoring Embryo laboratory intelligent monitoring system for real-time monitoring of lab environment and equipment.
  • BK-LMS Laboratory Management System Comprehensive laboratory management system used for managing reproductive medicine laboratories end-to-end.
  • BK-SMS Sample Management System Sample management system used for tracking, storage and management of biological samples in fertility labs.
  • BK-QCS Quality Control System Quality control management system used for analysis and management of laboratory QC data.

Companies that use Basecare

Customer profile

Segments3 records

Ideal customer profiles3 records

Basecare technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature13 records

Basecare partnerships and signals

Strategic signal

Recent moves5 records

Expansion highlights5 records

Basecare competitors and assessment

Company assessment

Direct peers

  • Vitrolife: Swedish provider of IVF media, consumables, and time-lapse embryo culture (Geri) systems. Direct overlap with Basecare's Gems, Geri, and embryo culture media lines, serving the same fertility clinic customers globally.
  • CooperSurgical (CooperCompanies): Major fertility and women's health company offering IVF lab consumables, devices, and PGT-related services. Comparable as a one-stop integrated IVF/PGT provider selling directly to fertility clinics and hospitals.
  • Hamilton Thorne: Specialty provider of IVF devices, lasers, and time-lapse imaging used in embryo research and ART clinics. Comparable instrument and consumable portfolio aligned with Basecare's DA500, BS1000, and Geri offerings.
  • BGI Genomics: China-based genomics and genetic testing leader, including NIPT and PGT services. Most direct domestic competitor in the Chinese PGT/NIPT space, targeting the same hospital and IVF clinic customers as Basecare.
  • Yikon Genomics: Chinese fertility genetics company focused on PGT-A/PGT-M embryo testing kits. Directly comparable to Basecare's BasePGT and BaseCNV products serving Chinese IVF centers.
  • Esco Medical: Provider of time-lapse embryo incubation systems (MIRI) and IVF lab equipment for ART clinics. Direct comparable to Basecare's Geri time-lapse incubator and the integrated IVF workstation segment.

Broad incumbents

  • Illumina: Dominant global DNA sequencing platform; powers many PGT workflows via sequencer and reagent sales. Broader incumbent with overlapping IVD/PGT technology stack though not a single-clinic integrated IVF supplier.
  • Thermo Fisher Scientific: Diversified life sciences tools, diagnostics, and lab services giant. Comparable as upstream supplier of IVF lab instruments and genetic testing reagents, though operates across many end markets.
  • Natera: Genetic testing company with established PGT (Spectrum) and reproductive health offerings. Comparable in reproductive genetics end-market though focused on US-centric clinical lab service delivery.

Emerging players

  • Genea Biomedx: Australian-based IVF technology developer behind Gavi (automated vitrification and handling), which Basecare lists in its own portfolio. Directly comparable on automated IVF workflow devices for fertility clinics.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights5 records

Customer concentration

Basecare social profiles

Digital presence

Basecare financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Basecare leadership team

Management profile

Number of profiles

Profiles1 record

Basecare funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Basecare M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Basecare

What does Basecare do?

Basecare develops and manufactures an integrated suite of IVF and reproductive genetics products, including preimplantation genetic testing kits (BaseECS, BasePGT, BaseCNV, BaseNIPT), diagnostic and sperm analysis instruments (DA500, BS1000), embryo culture and time-lapse observation systems (Gems, Geri, Gavi), sperm DNA fragmentation tests and quality controls (DFI, BFC260, DFI-QC, SEM-QC), cryopreservation consumables, and laboratory information management software (BaseStation, BK suite). Products are sold to fertility clinics, hospital reproductive medicine departments, and research institutions to support embryo screening, embryo culture, and IVF laboratory operations.

When was Basecare founded?

Basecare was founded in 2010. It employs 501 to 1,000 people.

Where is Basecare based?

Basecare is headquartered in Suzhou, China, in the Asia region.

How does Basecare make money?

Three revenue lines are on record. Medical Diagnostic Instruments are the primary driver. The others are diagnostic Reagents and Consumables and software Systems.

Who are Basecare's main competitors?

Direct peers on record are Vitrolife, CooperSurgical (CooperCompanies), Hamilton Thorne, BGI Genomics, Yikon Genomics and Esco Medical. Broad incumbents are Illumina, Thermo Fisher Scientific and Natera. Genea Biomedx is listed as an emerging player.

Does Basecare have an API?

No public API is recorded for Basecare.

What industry is Basecare in?

Basecare's product category is IVF and reproductive genetics medical devices. Its primary akta.pro industry code is HLAAALAJ, Prenatal, Newborn & Reproductive Diagnostics (NIPT, IVF/PGT, newborn screening), with a secondary code of HLAHAAAI, Genetic, Cytogenetic & Prenatal Screening IVD. Its NAICS code is 325414 and its SIC code is 2835.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireBasecare introduit le premier stock de séquençage génétique à la Bourse de Hong Kong, inaugurant ainsi la troisième génération de kits de FIV en ChineBasecare (Suzhou Basecare Medical Corporation Limited), an innovative genetic testing company for assisted reproduction, was officially listed on the HKEX (HKG: 2170) on February 9, 2021, raising HK$1.82 billion through approximately 66.67 million shares at HK$27.36 per share, with the offering oversubscribed 403 times and shares trading up 60% at publication. The company becomes the first gene sequencing firm listed on HKEX, opening the door to large-scale industrialization of third-generation IVF detection kits in China, where one in six couples faces fertility issues and the assisted reproduction medical device market reached 3.4 billion yuan in 2019 with a 28.4% compound annual growth rate. Basecare's PGT-A kit received National Medical Products Administration approval in February 2020 and has been integrated into mandatory national industrial standards as a Class III medical device since August 2020, with commercial insurance coverage of up to 400,000 yuan per test.PR NewswireBasecare listet erste Gene Sequencing Stock an der Hong Kong Stock Exchange Einweihung in Lizenzierte Ära von Chinas Third-Generation IVF KitBasecare (Suzhou Basecare Medical Corporation Limited), a reproductive genetics testing company, successfully listed on the Hong Kong Stock Exchange (HKG: 2170) on February 9, 2021, raising HK$1.82 billion through approximately 66.67 million shares at HK$27.36 per share, with shares oversubscribed 403 times. The listing makes Basecare the first gene sequencing stock on HKEX and marks China's entry into the licensed era of third-generation IVF genetic testing kits following NMPA approval of their PGT-A-Kit in February 2020. The company plans to establish its headquarters in Suzhou and build China's largest IVD industry chain and high-end medical device manufacturing cluster.PR NewswireBasecare la primera compañía de secuenciación genética en la Bolsa de Hong KongBasecare (Suzhou Basecare Medical Corporation Limited), a genetic testing company for assisted reproduction, completed its IPO on the Hong Kong Stock Exchange (HKEX: HKG:2170) on February 8, 2021, becoming the first genetic sequencing company listed on the exchange. The company raised approximately 1.82 billion HK dollars, issued 66.667 million shares at 27.36 HK dollars each, was oversubscribed 403 times, and saw its stock rise 60% with a market capitalization of 8.92 billion HK dollars. Basecare's PGT-A kit, China's first nationally approved third-generation IVF genetic testing kit, was incorporated into China's mandatory national standard as a Class III medical device in August 2020.PR NewswireBasecare Lists First Gene Sequencing Stock on Hong Kong Stock Exchange Ushering in Licensed Era of China's Third-Generation IVF KitBasecare (Suzhou Basecare Medical Corporation Limited), an innovative assisted reproductive genetic testing enterprise, officially listed on the main board of HKEX (HKG: 2170) on February 8, 2021, raising approximately HK$1.82 billion through 66.667 million shares with an initial price of HK$27.36 per share. The listing, which became the first gene sequencing stock on HKEX with shares oversubscribed 403 times and trading up 60%, positions the company to drive large-scale industrialization of third-generation IVF gene testing kits in China, where one in six couples faces fertility difficulties and the market is projected to reach CNY11.2 billion by 2024. Basecare's PGT-A kit, approved by China's National Medical Products Administration in February 2020 as a National Innovative Medical Device Special Approval product, forms the core of its full reproduction cycle product line.PR NewswireAssistierte Reproduktion Unicorn Basecare Medical geht in Hongkong an die BörseSuzhou Basecare Medical Co., Ltd. listed on the Hong Kong Stock Exchange on February 8, 2021, becoming a unicorn in the assisted reproduction sector. The company, founded in Jiangsu, China in 2019, offers China's first and only approved third-generation IVF product—a PGT-A testing kit for preimplantation genetic testing—having received registration approval from China's National Medical Products Administration. The company reported 35.48% revenue growth in the first nine months of 2020, reaching 15.61 million CNY with a profit margin of 48.2%, against a Chinese IVF market that expanded from 300 million CNY in 2015 to 2.5 billion CNY in 2019 at a 70.8% annual growth rate.PR NewswireProcréation assistée : la licorne Basecare Medical va être introduite en bourse à Hong KongSuzhou Basecare Medical Co., Ltd., a unicorn in China's assisted reproduction sector, completed its listing on the Hong Kong Stock Exchange on February 8, 2021. The company is the first and only firm to have a third-generation IVF product (PGT-A testing kit) approved and registered with China's National Medical Products Administration, generating a 48.2% profit margin and 35.48% revenue growth in the first nine months of 2020. The IPO follows rapid market expansion in China's IVF technology sector, which grew from 300 million CNY in 2015 to 2.5 billion CNY in 2019, and the company announced two additional PGT products (PGT-M and PGT-SR kits) planned for approval in 2022 and 2024 respectively.PR NewswireEl unicornio de la reproducción asistida Basecare Medical cotiza en Hong KongSuzhou Basecare Medical Co., Ltd. announced it will list on the Hong Kong Stock Exchange on February 8, 2021, positioning itself as a unicorn in China's assisted reproduction sector ahead of the IPO. The company holds China's first regulatory-approved PGT-A (pre-implantation genetic testing) kit, having generated 15.61 million CNY in revenue during the first nine months of 2020, a 35.48% year-on-year increase despite the COVID-19 pandemic. Frost & Sullivan projects China's IVF market will grow from 200 million CNY in 2015 to 25.5 billion CNY by 2024, while Basecare Medical is also advancing PGT-M and PGT-SR testing kits expected to receive regulatory approval in 2022 and 2024 respectively.